Specificity of methylation assays in cancer research: a guideline for designing primers and probes.
DNA methylation is an epigenetic regulation mechanism of genomic function, and aberrant methylation pattern has been found to be a common event in many diseases and human cancers. A large number of cancer studies have been focused on identification of methylation changes as biomarkers (i.e., breast cancer). However, still clinical use of them is very limited because of lack of specificity and sensitivity for diagnostic test. This highlights the critical need for specific primer and probe design to avoid false-positive detection of methylation profiling. The guideline and online web tools that are introduced in this paper might help to perform a successful experiment and to develop specific diagnosis biomarkers by designing right primer pair and probe prior to experimental step.
Barekati
Zeinab
Z
Laboratory for Gynecological Oncology, Women's Hospital and Department of Biomedicine, University of Basel, Basel 4031, Switzerland.
Radpour
Ramin
R
Kohler
Corina
C
Zhong
Xiao Yan
XY
Clin Chem. 2007 Dec;53(12):2119-27
17962364
Development. 1987 Mar;99(3):371-82
3653008
Biotechniques. 2003 Jul;35(1):152-6
12866415
J Urol. 2002 Apr;167(4):1854-8
11912447
Nucleic Acids Res. 2000 Apr 15;28(8):E32
10734209
Mol Cancer Res. 2008 Nov;6(11):1702-9
19010818
Clin Chem. 2009 Aug;55(8):1471-83
19520761
Cancer Res. 1999 Jan 1;59(1):67-70
9892187
Cancer Res. 2004 Jul 1;64(13):4442-52
15231653
Methods. 2001 Dec;25(4):456-62
11846615
Nucleic Acids Res. 2002 Mar 15;30(6):e25
11884644
Nucleic Acids Res. 2008 Apr;36(7):e42
18344521
Nat Rev Genet. 2002 Jun;3(6):415-28
12042769
Methods Mol Biol. 2009;507:207-27
18987817
EXS. 1993;64:358-84
7678203
Clin Chem. 2001;47(7):1183-9
11427447
Mod Pathol. 2010 May;23(5):763-72
20081803
Cancer Res. 1999 Aug 15;59(16):3899-903
10463578
Nucleic Acids Res. 2004 Jan 13;32(1):e10
14722226
J Biol Chem. 1997 Aug 29;272(35):22322-9
9268383
Nucleic Acids Res. 1997 Jun 15;25(12):2529-31
9171109
Biochemistry. 1970 Jul 7;9(14):2858-65
5459538
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3740-5
11891299
J Biochem Biophys Methods. 2006 Mar 31;66(1-3):33-43
16442635
Cancer Res. 2000 Feb 1;60(3):702-6
10676656
Mol Carcinog. 2001 Sep;32(1):19-27
11568972
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Hum Mol Genet. 2010 Aug 1;19(15):2936-46
20466735
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31
1542678
N Engl J Med. 2008 Mar 13;358(11):1148-59
18337604
Development. 2007 Nov;134(22):3959-65
17928417
Expert Rev Mol Diagn. 2007 Sep;7(5):519-31
17892361
Nucleic Acids Res. 1997 Jun 15;25(12):2532-4
9171110
Nat Rev Cancer. 2003 Apr;3(4):253-66
12671664
Biotechniques. 2003 Jul;35(1):146-50
12866414
Genet Test Mol Biomarkers. 2009 Oct;13(5):565-71
19814613
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15785-90
16243968
Biotechnol Lett. 2004 Aug;26(16):1289-93
15483389
Epigenetics Chromatin. 2008 Nov 03;1(1):7
19014416
Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):576-81
17693740
Oncogene. 2002 Aug 12;21(35):5462-82
12154408
Gastroenterology. 2009 Feb;136(2):640-51.e1
19084528
Lab Invest. 2001 Apr;81(4):635-8
11304583
Eur J Haematol. 2006 Jan;76(1):23-32
16343268
Oncogene. 2009 Aug 20;28(33):2969-78
19503099
Anal Biochem. 2003 Jun 15;317(2):259-65
12758266
Biosens Bioelectron. 2008 Apr 15;23(9):1333-9
18215791
Nucleic Acids Res. 1994 Aug 11;22(15):2990-7
8065911
Genes Dev. 2002 Jan 1;16(1):6-21
11782440
J Pathol. 2002 Jan;196(1):1-7
11748635
Biochem Biophys Res Commun. 1970 Aug 24;40(4):839-43
5495733